Oscar Health, Inc. (OSCR)
NYSE: OSCR · Real-Time Price · USD
14.68
-0.25 (-1.67%)
At close: Aug 14, 2025, 4:00 PM
15.03
+0.35 (2.38%)
After-hours: Aug 14, 2025, 6:56 PM EDT
Oscar Health Revenue
Oscar Health had revenue of $2.86B in the quarter ending June 30, 2025, with 29.04% growth. This brings the company's revenue in the last twelve months to $10.73B, up 48.29% year-over-year. In the year 2024, Oscar Health had annual revenue of $9.18B with 56.54% growth.
Revenue (ttm)
$10.73B
Revenue Growth
+48.29%
P/S Ratio
0.34
Revenue / Employee
$4,469,219
Employees
2,400
Market Cap
3.79B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
OSCR News
- 11 hours ago - Hy-Vee Health and Oscar Serve Up a New Era of Employer Healthcare - Business Wire
- 6 days ago - Wall Street Got Oscar All Wrong - Seeking Alpha
- 7 days ago - Oscar Health, Inc. (OSCR) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Obamacare Insurer Oscar Health, Hit By Higher Costs, Sees 2026 Rebound - Forbes
- 8 days ago - Oscar Health Announces Financial Results for Second Quarter 2025 and Reaffirms Updated 2025 Guidance - Business Wire
- 9 days ago - Oscar Health: Underrated Growth Story With Big-Cap Ambitions - Seeking Alpha
- 10 days ago - Oscar Health Ahead Of Q2: Brace For Strategic Reset - Seeking Alpha
- 23 days ago - Oscar Health Announces Preliminary Financial Results for Second Quarter 2025 and Revises 2025 Guidance - Business Wire